The role of endocrine therapy in prostatic cancer.

  title={The role of endocrine therapy in prostatic cancer.},
  author={Colby L. Eaton and Keith Griffiths},
  journal={Bailliere's clinical endocrinology and metabolism},
  volume={4 1},
When judged by randomized clinical trial, current endocrine therapies offer symptomatic relief to prostatic cancer patients for an average period of 1-2 years following initiation of therapy. Medical castration with LHRH analogues is a safe and effective way of achieving 'castrate' levels of circulating androgens without the undesirable aspects of surgery. While there is some evidence for the value of combined therapies using these agents in combination with anti-androgens for 'total androgen… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.

Similar Papers

Loading similar papers…